Ye Fu

Ye Fu Email and Phone Number

Chief Scientific Officer and Co-Founder @ Stellaromics Inc.
Boston, MA, US
Ye Fu's Location
Cambridge, Massachusetts, United States, United States
Ye Fu's Contact Details
About Ye Fu

Dr. Ye Fu, Ph.D., is a seasoned biotech innovator with a research portfolio encompassing biochemistry, biophysics, structural biology, and genomics. With a Ph.D. in Chemistry from the University of Chicago, mentored by Professor Chuan He, Dr. Fu’s PhD thesis opened the field of reversible RNA modifications, which is the foundational work for the prestigious 2023 Wolf Prize in Chemistry. With numerous patents and publications including first-author articles in Cell and Nature Chemical Biology, Dr. Fu's work has garnered over 18,000 citations. As Principal at Plaisance Capital Management, Dr. Fu spearheaded the incubation and management of groundbreaking biotech firms, including Aferna Bio, Sedec Therapeutics, ProteoValent Therapeutics and Stellaromics, where he serves as co-founder and Chief Technology Officer. He also actively participates in advising early-to-mid stage biotech enterprises. Full publication list:https://scholar.google.com/citations?user=7XlJ0roAAAAJ&hl=enSpecialties: RNA Methylation, mRNA, tRNA, DNA modification, Protein Modification, Liquid-Liquid Phase Separation, Spatial Transcriptomics, Biochemistry, Bioorganic Chemistry, RNA Chemical Biology, Genomics, Epitranscriptomics, Epigenetics, Therapeutics

Ye Fu's Current Company Details
Stellaromics Inc.

Stellaromics Inc.

View
Chief Scientific Officer and Co-Founder
Boston, MA, US
Website:
stellaromics.com
Employees:
49
Ye Fu Work Experience Details
  • Stellaromics Inc.
    Chief Scientific Officer And Co-Founder
    Stellaromics Inc.
    Boston, Ma, Us
    View
  • Stellaromics Inc.
    Chief Technology Officer And Co-Founder
    Stellaromics Inc. Oct 2023 - Present
    Boston, Massachusetts, Us
    Stellaromics' technology captures high resolution 3D multi-omic information from thick tissue samples with intact tissue architecture, fully mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells being studied.
    View
  • Stellaromics Inc.
    Interim Chief Technology Officer
    Stellaromics Inc. Sep 2022 - Oct 2023
    Boston, Massachusetts, Us
    View
  • Sedec Therapeutics
    Board Member
    Sedec Therapeutics Mar 2023 - Present
    View
  • Sedec Therapeutics
    Director Of Chemical Biology
    Sedec Therapeutics Jan 2021 - Mar 2023
    Developing the next-generation autoimmune and immune-oncology therapeutics by targeting STAT3 palmitoylation pathway.
    View
  • Aferna Bio
    Consultant
    Aferna Bio Oct 2023 - Present
    View
  • Aferna Bio
    Director Of Innovation
    Aferna Bio Feb 2022 - Oct 2023
    Developing novel technologies by modulating epigenetic factors for agriculture and carbon fixation.
    View
  • Plaisance Capital Management Llc
    Principal
    Plaisance Capital Management Llc Aug 2020 - Oct 2023
    Natick, Massachusetts, Us
    Exploring innovative ideas and developing scientific strategies to create breakthrough companies in the biotech space.
    View
  • Harvard University
    Postdoctoral Research Fellow
    Harvard University Sep 2014 - Jul 2020
    Cambridge, Massachusetts, Us
    Use super-resolution Stochastic Optical Reconstruction Microscopy (STORM) and Multiplexed Error Robust Fluorescence In Situ Hybridization (MERFISH) to study the biology of DNA and RNA modifications in eukaryotes.
    View
  • The University Of Chicago
    Postdoctoral Researcher
    The University Of Chicago Dec 2012 - Jul 2014
    Chicago, Il, Us
    Developed high-throughput sequencing methods to study the function of epigenetic m6A modifications in DNA and RNA in green algae Chlamydomonas.
    View
  • The University Of Chicago
    Graduate Student And Research Assistant
    The University Of Chicago Oct 2007 - Dec 2012
    Chicago, Il, Us
    Using various tools and technologies from organic chemistry, biochemistry, bioinformatics, and cell physiology to probe the physiological and biochemical role of Fe(II)/2-oxoglutarate dependent hydroxylase family proteins. Functions of these proteins include DNA/RNA repair, DNA/RNA/protein modification, and are related to embryonic development, cancer, and obesity.
    View
  • Peking University
    Undergraduate Research
    Peking University Sep 2003 - Jun 2007
    北京, Beijing, Cn
    Developing new organic synthetic methodology including Pd catalyzed C-H activation reaction, and Au catalyzed cross-coupling reaction.
    View

Ye Fu Skills

Biochemistry Organic Chemistry Chemistry Genomics Cancer Organic Synthesis

Ye Fu Education Details

  • University Of Chicago
    University Of Chicago
  • Peking University
    Peking University
    Chemistry

Frequently Asked Questions about Ye Fu

What company does Ye Fu work for?

Ye Fu works for Stellaromics Inc.

What is Ye Fu's role at the current company?

Ye Fu's current role is Chief Scientific Officer and Co-Founder.

What is Ye Fu's email address?

Ye Fu's email address is ye****@****ard.edu

What schools did Ye Fu attend?

Ye Fu attended University Of Chicago, Peking University.

What skills is Ye Fu known for?

Ye Fu has skills like Biochemistry, Organic Chemistry, Chemistry, Genomics, Cancer, Organic Synthesis.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.